AeroRx Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $20.8M

  • Investors
  • 4

AeroRx Therapeutics General Information

Description

Developer of combination drug therapies intended for respiratory disease treatment. The company develops treatments delivered via nebulization, focusing on older patients with chronic obstructive pulmonary disease, enabling patients to receive effective and targeted care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • La Jolla, CA 92037
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Drug Delivery
Vertical(s)
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • La Jolla, CA 92037
  • United States
+1 (858)

AeroRx Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AeroRx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 07-Oct-2025 $20.8M Completed Clinical Trials - Phase 2
1. Seed Round 30-Apr-2024 Completed Clinical Trials - Phase 2
To view AeroRx Therapeutics’s complete valuation and funding history, request access »

AeroRx Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view AeroRx Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AeroRx Therapeutics Patents

AeroRx Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024206662-A1 Liquid formulations of indacaterol and glycopyrronium Inactive 30-Mar-2023
EP-4499099-A1 Liquid formulations of indacaterol and glycopyrronium Pending 30-Mar-2022
EP-4499099-A4 Liquid formulations of indacaterol and glycopyrronium Pending 30-Mar-2022
US-20250177372-A1 Liquid formulations of indacaterol and glycopyrronium Pending 30-Mar-2022
WO-2023192445-A1 Liquid formulations of indacaterol and glycopyrronium Inactive 30-Mar-2022 A61K31/4704
To view AeroRx Therapeutics’s complete patent history, request access »

AeroRx Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AeroRx Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Correlation Ventures Venture Capital Minority
Prebys Ventures Impact Investing Minority
Avalon Bioventures Venture Capital Minority
To view AeroRx Therapeutics’s complete investors history, request access »

AeroRx Therapeutics FAQs

  • When was AeroRx Therapeutics founded?

    AeroRx Therapeutics was founded in 2022.

  • Where is AeroRx Therapeutics headquartered?

    AeroRx Therapeutics is headquartered in La Jolla, CA.

  • What is the size of AeroRx Therapeutics?

    AeroRx Therapeutics has 3 total employees.

  • What industry is AeroRx Therapeutics in?

    AeroRx Therapeutics’s primary industry is Drug Discovery.

  • Is AeroRx Therapeutics a private or public company?

    AeroRx Therapeutics is a Private company.

  • What is the current valuation of AeroRx Therapeutics?

    The current valuation of AeroRx Therapeutics is .

  • What is AeroRx Therapeutics’s current revenue?

    The current revenue for AeroRx Therapeutics is .

  • How much funding has AeroRx Therapeutics raised over time?

    AeroRx Therapeutics has raised $26.8M.

  • Who are AeroRx Therapeutics’s investors?

    Alexandria Venture Investments, Correlation Ventures, Prebys Ventures, and Avalon Bioventures have invested in AeroRx Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process